Atlas Trials

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

Clinical trial NCT02112656 · COMPLETED

Trial details

NCT number
NCT02112656
Sponsor
Imunon
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2014-06-01
Primary completion
2020-04-27
Enrollment
554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.